Picture of Feedback logo

FDBK Feedback News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

REG - Feedback PLC - Directorate Change

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251020:nRST9219Da&default-theme=true

RNS Number : 9219D  Feedback PLC  20 October 2025

Feedback plc

 

Directorate change

Appointment of CFO

 

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical
infrastructure specialist, announces that Anesh Patel, Chief Financial
Officer, has informed the Board of his intention to step down from his role to
pursue another opportunity. Anesh will step down from the Board of directors
of the Company and its subsidiaries with effect from 10 November 2025, but to
support an orderly handover will remain in post with the Company for a number
of weeks following the commencement of employment of a successor.

 

The Board is pleased to announce it has appointed Emma Oswick (Stuart) to
succeed Anesh. Emma will assume the role of CFO on 10 November 2025 and is
expected to join the Board of directors in due course.

 

Emma Oswick (Stuart) is an experienced and commercially focussed CFO with an
extensive background in subscription-led technology businesses, including in
her most recent role as Interim CFO of Energy Aspects. She is a Chartered
Accountant, having qualified with PwC, and has a proven track record of
driving strategic change, optimising financial performance, and developing
high-performing teams. She also brings significant M&A and integration
experience and is passionate about technology and its role in process
improvement.

 

Dr Tom Oakley, CEO of Feedback plc, said: "On behalf of the Board, we would
like to thank Anesh for his significant contributions and services to the
Company during his tenure. Anesh has been instrumental in helping to establish
a scalable platform to deliver our ambitious growth strategy. We wish Anesh
every success in his new role, and we look forward to welcoming Emma to the
team. Emma is joining at an exciting time for the business and brings a wealth
of experience that will be invaluable to Feedback's evolution.

 

Anesh Patel, outgoing CFO of Feedback plc, said: "It has been a pleasure being
part of Feedback's journey. The team has developed an outstanding product with
clear, proven benefits for healthcare systems, ensuring that the Company is
well set for growth. I would like to thank the Board and wider team for their
support, and I wish them the very best for the future."

 

Emma Oswick (Stuart), incoming CFO of Feedback plc, said: "I am delighted to
be joining Feedback at a such a pivotal time for technology in the healthcare
sector.  Feedback's innovative workflow and collaboration solutions are
transforming how medical professionals deliver care and are improving outcomes
for patients. I'm excited to work alongside the leadership team to support
Feedback's growth story."

 

-Ends-

 

 

 

 

Enquiries:

 

 Feedback plc                                +44 (0) 20 3997 7634

 Tom Oakley, CEO                             IR@fbk.com (mailto:IR@fbk.com)

 Anesh Patel, CFO

 Panmure Liberum Limited (NOMAD and Broker)  +44 (0)20 7886 2500

 Emma Earl/Mark Rogers (Corporate Finance)

 Rupert Dearden (Corporate Broking)

 Walbrook PR Ltd;                            Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
                                             (mailto:feedbackplc@walbrookpr.com)
 Nick Rome/Joe Walker                        07748 325 236 or 07407 020 470

 

 

About Feedback plc

 

Feedback plc liberates the data and knowledge from multiple healthcare IT
systems and delivers better workflow to enable clinicians to communicate,
collaborate and provide the best healthcare for their patients. We connect
care settings with diagnostic and other relevant data to drive better, faster,
safer decision that improve outcomes for patients.

 

By linking different clinical systems together into a seamless view of the
patient, we can streamline patient pathways and deliver a digital health and
diagnostics record across multiple care providers.

 

Bleepa® is our communication and collaboration platform that displays
clinical results at a certified and regulated quality, which enables
multi-disciplinary team working and diagnostic-enhanced advice and guidance.
CareLocker® is our patient-facing platform that gives patients access and
control over their diagnostic and other clinical data.

 

The Company has a number of growth opportunities domestically and
internationally across a range of public and private healthcare markets
including the NHS. Our highly scalable software-as-a-service (SaaS) based
model is expected to provide increasing levels of revenue visibility as the
Company grows its customer base.

 

https://feedbackmedical.com/
(https://urldefense.proofpoint.com/v2/url?u=https-3A__feedbackmedical.com_&d=DwMGaQ&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=lwwmT1lSfgELFLcwvlJQ2ZXDKcVbkQyitKwD17cChBQ&m=oBFM-ht-5vvdSXufzCuQmLfPWIaMcFGcjFY8Tl7Z-dsq0iW8FbXgExGw9gLP3va-&s=kayb21_5OhwDnHa1pJnJQjB1999VQgQynAFl7rWXro4&e=)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAMRBRTMTIBBAA



            Copyright 2019 Regulatory News Service, all rights reserved

Recent news on Feedback

See all news